Jessica Cassara Hochberg MD
Associate Professor, Pediatrics, New York Medical College
Join to View Full Profile
19 Skyline DriveOffice 1N-D12Valhalla, NY 10595
Phone+1 914-614-4270
Dr. Hochberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jessica Hochberg is a Pediatric Hematologist/Oncologist based in Valhalla, NY, affiliated with Boston Children's Hospital, Maria Fareri Children’s Hospital and New York Medical College as an Associate Professor of Pediatrics since 2009. She completed her medical degree at the University of Massachusetts Medical School, followed by a residency in Pediatrics and a fellowship in Pediatric Hematology/Oncology at Columbia New York Presbyterian Hospital. Her expertise covers a wide range of pediatric hematology and oncology conditions, including a primary focus lymphoma and leukemia as Director of the Hematologic Malignancy Program. Dr. Hochberg has published research on topics such as targeted immunotherapy for Hodgkin lymphoma, anticoagulation in acute lymphoblastic leukemia or lymphoma, and treatment strategies for non-Hodgkin lymphoma. She is actively involved in clinical trials focusing on innovative therapies for pediatric lymphoma and leukemia.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
UMass Chan Medical SchoolResidency, Pediatrics, 2003 - 2006- University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
NY State Medical License 2006 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients Start of enrollment: 2014 Mar 01
Roles: Contact
- Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL Start of enrollment: 2015 Aug 21
Roles: Contact
- Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma Start of enrollment: 2023 Aug 24
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Targeted immunotherapy in the treatment of childhood and adolescent classic Hodgkin lymphoma.Ana C Xavier, Jessica Hochberg, Mitchell S Cairo
Clinical Advances in Hematology & Oncology. 2024-12-01 - 12 citationsApixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-AL...Sarah H O'Brien, Vilmarie Rodriguez, Glen Lew, Jane W Newburger, Corinna L Schultz
The Lancet. Haematology. 2024-01-01 - 7 citationsDiagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.Jennifer A Belsky, Jessica Hochberg, Lisa Giulino-Roth
Best Practice & Research. Clinical Haematology. 2023-03-01
Professional Memberships
- Member
- American Society of Pediatric Hematology and Oncology - ASPHOMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
